OrthoPediatrics Corp. Continued Leading Sponsorship at 2025 POSNA Annual Meeting
OrthoPediatrics (NASDAQ: KIDS) announced its continued role as the exclusive Emerald Sponsor for the 2025 Pediatric Orthopaedic Society of North America (POSNA) annual meeting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics (NASDAQ: KIDS) announced its continued role as the exclusive Emerald Sponsor for the 2025 Pediatric Orthopaedic Society of North America (POSNA) annual meeting. The company will showcase its expanding pediatric-specific solutions, including OrthoPediatrics Specialty Bracing and Enabling Technologies, across three exhibit booths. As part of its long-term commitment to POSNA, OrthoPediatrics provides support through specialty symposiums, educational grants, and scholarships for attendees.
Details
News Market Reaction – KIDS
The recorded move for KIDS in the trading session of this news was -1.55%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Reinforced Long-Term Commitment as Emerald Sponsor
WARSAW, Ind., May 14, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the 2025 Pediatric Orthopaedic Society of North America (“POSNA”) annual meeting as an Emerald Sponsor.
At the Annual Meeting, the Company will highlight its growing portfolio of pediatric-specific solutions, including OrthoPediatrics Specialty Bracing (“OPSB”) and Enabling Technologies, at its three exhibit booths. OrthoPediatrics has established a long-term commitment to POSNA providing ongoing support of specialty symposiums and awarding educational grants and scholarships to attendees. The Company is the only Emerald Sponsor of the meeting.
OrthoPediatrics’ President & CEO, David Bailey, commented, “It is a privilege to once again support POSNA and strengthen our valued relationship with such a respected organization. At OrthoPediatrics, we are fully committed to the shared goals of POSNA to drive progress within pediatric orthopedics. This annual meeting brings together industry leaders and solutions that are positively impacting children’s lives, and we are very proud of the role we play in furthering that mission.”
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 80 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 70 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.